Welcome to the press section. If you want to be included in our media database, please send us an email.

BRAIN AG announces the creation of SolasCure Ltd. to continue development of Aurase®

  • Successful close of SolasCure’s Series A financing round with participation from BRAIN
  • SolasCure brings expertise in the development and approval of medical devices; Prof. Keith Harding (CBE) acting as Chairman of the Medical Advisory Board
  • BRAIN is providing IP and fully integrating their development programme for biological wound care based on the Aurase® enzyme into SolasCure